Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Supira Medical, founded in 2012 and based in Los Gatos, California, is a medical innovation company specializing in advanced healthcare solutions. Their primary focus is the development of a low-profile, high continuous flow percutaneous ventricular assist device (pVAD). This innovative device provides temporary mechanical support to assist the heart's pumping action, enabling high-risk patients to undergo necessary interventional procedures and aiding those suffering from cardiogenic shock.
Since its inception, Supira Medical has raised a total of $122.61 million in funding, demonstrating significant investor interest in their groundbreaking technology. The company's commitment to addressing critical needs in cardiovascular care has positioned them as a notable player in the medical device industry.
While there is currently no concrete information available regarding Supira Medical's IPO prospects, it's important to note that companies in the healthcare and medical technology sectors often consider going public as a means to fund further research and development or expand their market presence. However, the decision to pursue an IPO depends on various factors, including market conditions, company readiness, and strategic goals.
Investors interested in the medical technology sector may want to keep an eye on Supira Medical's progress and any potential announcements regarding their future plans. As always, it's crucial to conduct thorough research and consider multiple factors before making any investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Supira Medical's IPO prospects remain uncertain, investors eager to explore opportunities in the medical device industry don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential leaders in the healthcare and medical technology sectors, with lower minimum investments than traditional private equity opportunities. By investing through Linqto, you could potentially benefit from Supira Medical's growth and innovation in the cardiovascular space before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
